ResearcherEmory UniversityNo recent work listed

Hongyu Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5852-3953; OpenAlex author ID A5023834243. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2015: 1 paper

Papers 1

IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer. Co-author DOI 10.1021/acsnano.5b01288 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hui Mao · 1 shared paper, 2015 · strength 0.05
- Paper IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer. DOI 10.1021/acsnano.5b01288 ↗
David A. Kooby · 1 shared paper, 2015 · strength 0.05
- Paper IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer. DOI 10.1021/acsnano.5b01288 ↗
Liya Wang · 1 shared paper, 2015 · strength 0.05
- Paper IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer. DOI 10.1021/acsnano.5b01288 ↗
Lily Yang · 1 shared paper, 2015 · strength 0.05
- Paper IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer. DOI 10.1021/acsnano.5b01288 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.